Monopar shareholders re-elect all directors, approve 2026 stock plan, ratify BPM

Monopar Therapeutics

All six director nominees elected: Starr (4.20M for), Robinson (4.45M), Anderson (4.67M), Tsuchimoto (4.33M), Talukdar (4.90M), Sweeny (4.91M).
Advisory say-on-pay passed with 4.36M for, 605k against, 651 abstain.
2026 Stock Incentive Plan approved with 4.44M for, 517k against.
Ratification of BPM LLP as auditor for FY2026 passed with 5.76M for, 998 against.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.